Richard Pierce, MD
Dermatology · Charleston, SCNPI 1649619404
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by AbbVie at 43.7% of the total. 2025 is the largest year on record at $170, 5.7 times the $30 reported in 2021. That places this record below the midpoint for dermatology clinicians in SC, where the typical reported total is $3,326.
Across 19 payments — averaging $23.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$196
- Arcutis Biotherapeutics, Inc.$106
- Galderma Laboratories, L.p.$47
- E.r. Squibb & Sons, L.L.C.$38
- Dermavant Sciences, Inc.$24
- Incyte Corporation$22
- plus $16 from 1 others
What the payments were for
- Food & beverage$449100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 9 | $196 |
| Arcutis Biotherapeutics, Inc. | 2 | $106 |
| Galderma Laboratories, L.p. | 3 | $47 |
| E.r. Squibb & Sons, L.L.C. | 2 | $38 |
| Dermavant Sciences, Inc. | 1 | $24 |
| Incyte Corporation | 1 | $22 |
| LEO Pharma Inc. | 1 | $16 |
How this compares
$449 in reported general payments places this provider in the 15th percentile of 203 dermatology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OtezlaApremilast | 11 | $53,887 |
| Ketoconazole | 184 | $2,597 |
| Clobetasol Propionate | 73 | $2,441 |
| Fluorouracil | 29 | $1,798 |
| Doxycycline Hyclate | 126 | $1,541 |
| ValacyclovirValacyclovir Hcl | 23 | $542 |
| Triamcinolone Acetonide | 48 | $301 |
| Hydrocortisone | 39 | $132 |
| Prednisone | 15 | $34 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Charleston
- Todd SchlesingerCharleston$1.9M
- Mark SiegelCharleston$120K
- Erin WalkerCharleston$20K
- Alan SnyderCharleston$13K
- David SmithCharleston$12K
- Marshall ShulerGreenville$2.6M
- Rebecca SmithFort Mill$2.3M
- Amylynne FrankelSpartanburg$987K
- Marguerite GermainMt Pleasant$200K
- George KeoughPawleys Island$150K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.